Two-quarters of pork prices continue to rise

Two-quarters of pork prices continue to rise As several major holidays such as the New Year's Day Spring Festival are coming, the price of pork has come out of the low point and has risen significantly. Since December, the price of pork, pork, ribs, etc. has increased by 1 yuan per catty.

On December 16th, in the Dongcheng Haihe Farmer's Market and the peaceful farmers' market, we can see that the pork market retail price is lean meat 12.5 yuan / kg, pork 11.5 yuan / kg, ribs 15 yuan / kg, each catty rose 1 yuan. Pork retailers said that the rise in pork prices is mainly due to the sharp rise in the price of live pigs. Currently, the price of live pigs has exceeded RMB 10/kg, and there is still much room for growth.

There are many factors in the rise of pork prices: New Year's Day is approaching, and the Spring Festival follows closely. Pork is a necessary product and has become the main cause of rising prices. Since last year, pork prices have been operating at a low level, resulting in a decline in the enthusiasm of farmers. Since the Spring Festival this year, farmers have made a profit. Small, some small farmers withdrew, and the amount of live pigs went down. The cost of raising the livestock has increased. Since the spring of this year, the price of corn has gone up and it has been operating at a high level, which has affected the scale of farming to some extent. According to industry insiders' predictions, there is room for further increase in pork prices in the near future, and it is estimated that the current price will increase by 1 yuan per catty.

Anti-Respiratory

Respiratory disease is a common disease, frequently-occurring disease, the main lesion in the trachea, bronchi, lung and chest, lesions are more cough, chest pain, respiratory effects, severe breathing difficulties, hypoxia, and even respiratory failure and death. Due to air pollution, smoking and other factors, The chronic obstructive pulmonary disease is increasing including chronic bronchitis, emphysema, pulmonary heart disease, bronchial asthma, lung cancer, pulmonary diffuse interstitial fibrosis, and pulmonary infection the morbidity and mortality of the disease at home and abroad . Therefore, anti-respiratory disease drugs are also more and more attention paid by researchers. Respiratory disease have the symptoms of cough, sputum, hemoptysis, chest pain, shortness of breath and other symptoms of lack of specificity, often clinicians mistaken by people for colds, bronchitis, and severe pneumonia, tuberculosis or lung cancer and other diseases delayed diagnosis; Respiratory tract infection, to be developed to emphysema, pulmonary heart disease, respiratory failure was taken seriously, but it was too late, its pathology and physiological function has been difficult to reverse. As with other systemic diseases, careful and detailed medical history and physical examination are the basis for the diagnosis of respiratory diseases, and should be combined with routine laboratory tests and other special findings to conduct a comprehensive and comprehensive analysis. Currently the most clinical application of anti-respiratory disease drugs have the following four categories: 1. Antihistamines 2. Cough medicine 3. Bronchodilator 4. Expectorant 5. Anti-asthma drugs.

Anti-asthma Drugs, Antitussives, Expectorants, β adrenergic receptor agonists, M Cholinergic Blockers, Phosphodiesterase Inhibitors, Anti-Respiratory Drugs,Respiratory System Diseases Treatment

Taizhou Volsen Chemical Co., Ltd. , https://www.volsenchem.com